Device shows potential in preventing stroke by blocking clots

10/3/2013 | Charleston Regional Business Journal (S.C.)

PMG Research is conducting a clinical trial comparing the effectiveness of St. Jude Medical's Amplatzer cardiac plug, an anti-clotting device, to anticoagulant therapy. The device is inserted into a patient's leg via catheter and blocks part of the heart to keep clots from flowing into the bloodstream. Researcher Dr. Matthew O'Steen said the Amplatzer shows promise in stroke prevention.

View Full Article in:

Charleston Regional Business Journal (S.C.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC